Blood tests that could spot early signs of cancers to be trialled on thousands of NHS patients

Thousands of NHS patients are set to participate in a trial for innovative blood tests designed to detect early signs of several common cancers. This initiative aims to catch malignancies at their earliest stages, potentially improving survival rates and reducing the need for extensive treatment. The trial's success could lead to widespread adoption within the NHS, marking a significant step forward in cancer screening and treatment. This move underscores the NHS's commitment to leveraging cutting-edge medical technology to enhance patient outcomes.